The invention provides for the transdermal delivery of the active enantiomer of the analgesic ketorolac. Transdermal patches according to the invention are capable of delivering (-) ketorolac to a patient at therapeutically effective levels, at a flux rate of 20 .mu.g/cm.sup.2.hr or more. Patches for...http://www.google.com/patents/US5589498?utm_source=gb-gplus-sharePatent US5589498 - Transdermal delivery of the active enantiomer of ketorolac
